Disease Activity

Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA)
Polina Putrik, Sofia Ramiro, Anna Moltó, Andras P Keszei, Sam Norton, Maxime Dougados, Désirée van der Heijde, Robert B M Landewé, Annelies Boonen

Annals of the Rheumatic Diseases Apr 2019, 78 (4) 486-493; DOI: 10.1136/annrheumdis-2018-214259
Wrist ultrasound - the model method for grey-scale and power Doppler scoring
Nirupam Purkayastha, Frances Humby, Vidalba Rocher-Ros, Costantino Pitzalis, Stephen Kelly

Annals of the Rheumatic Diseases Mar 2019, 78 (3) 441-442; DOI: 10.1136/annrheumdis-2018-213977
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity
Diogo Jesus, Ana Matos, Carla Henriques, Margherita Zen, Maddalena Larosa, Luca Iaccarino, José António Pereira Da Silva, Andrea Doria, Luís Sousa Inês

Annals of the Rheumatic Diseases Mar 2019, 78 (3) 365-371; DOI: 10.1136/annrheumdis-2018-214502
Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis
Murray B Urowitz, Robert L Ohsfeldt, Ronald C Wielage, Kari A Kelton, Yumi Asukai, Sulabha Ramachandran

Annals of the Rheumatic Diseases Mar 2019, 78 (3) 372-379; DOI: 10.1136/annrheumdis-2018-214043
When binary and continuous responses disagree
Fengchen Ouyang

Annals of the Rheumatic Diseases Jan 2019, annrheumdis-2018-214968; DOI: 10.1136/annrheumdis-2018-214968
Response to ‘‘To switch or not to switch’: the missing piece in the puzzle of biosimilar literature?’ by Scherlinger et al
Bente Glintborg, Anne Gitte Loft, Emina Omerovic, Oliver Hendricks, Asta Linauskas, Jakob Espesen, Kamilla Danebod, Dorte Vendelbo Jensen, Henrik Nordin, Emil Barner Dalgaard, Stavros Chrysidis, Salome Kristensen, Johnny Lillelund Raun, Hanne Lindegaard, Natalia Manilo, Susanne Højmark Jakobsen, Inger Marie Jensen Hansen, Dorte Dalsgaard Pedersen, Inge Juul Sørensen, Lis Smedegaard Andersen, Jolanta Grydehøj, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland

Annals of the Rheumatic Diseases Jan 2019, annrheumdis-2018-214952; DOI: 10.1136/annrheumdis-2018-214952
Response to: ‘Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?’ by Suyama and Okada
Jun Won Park, Jeffrey R Curtis, Eun Bong Lee

Annals of the Rheumatic Diseases Feb 2019, 78 (2) e18; DOI: 10.1136/annrheumdis-2018-213045
Response to: ‘Bisphosphonates reduce the risk of knee replacement: we need more analyses!’ by Li et al
Tuhina Neogi, Shanshan Li, Christine Peloquin, Devyani Misra, Yuqing Zhang

Annals of the Rheumatic Diseases Feb 2019, 78 (2) e16; DOI: 10.1136/annrheumdis-2018-213094
Response to: ‘Association between bisphosphonate use and risk of undergoing knee replacement in osteoarthritis patients’ by Chen et al
Tuhina Neogi, Shanshan Sheehy, Christine Peloquin, Devyani Misra, Yuqing Zhang

Annals of the Rheumatic Diseases Feb 2019, 78 (2) e14; DOI: 10.1136/annrheumdis-2018-213018
Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?
Yasuhiro Suyama, Masato Okada

Annals of the Rheumatic Diseases Feb 2019, 78 (2) e17; DOI: 10.1136/annrheumdis-2018-213027

Main menu

Disease Activity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Disease Activity

Pages